Rising Pharma Holding, Inc.: Duloxetine DR Capsules USP 60 mg, a) 30 count and
Recall reason: CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit.. Recalled by Rising Pharma Holding, Inc.. Distribution: Nationwide. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot # a) DT6023053A, DT6023061A, DT6023068A, DT6023074A, exp. date Jan-25; DT6023078A, DT6023076A, exp. date Feb-25; D. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report